6 March 2026
Latham Advises on BrightSpring’s Secondary Offering of Common Stock and Concurrent Share Repurchase
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Marc Jaffe Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Ian Schuman Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Kaj Nielsen Lead | Latham & Watkins LLP | Partner | Capital Markets | Not stated |
| Molly Mitchell | Latham & Watkins LLP | Associate | Capital Markets | Not stated |
| Nicole Liffrig Molife | Latham & Watkins LLP | Counsel | healthcare | Not stated |
| Margaret Rote | Latham & Watkins LLP | Associate | healthcare | Not stated |
| Elena Romanova | Latham & Watkins LLP | Partner | tax | Not stated |
| Jack Santoro | Latham & Watkins LLP | Associate | tax | Not stated |
Stated terms
- Stated value
- USD 41.1 (US$41.15 per share)
- What the figure measures
- Per share
- Client
- Not stated
- Counterparties
- BrightSpring Health Services, Inc. (Issuer)
Kohlberg Kravis Roberts & Co. L.P. (Sell-side)